Por: The Hill Politics April 21, 2023
The leaders of the three main insulin manufacturers will testify at a Senate Health Committee hearing on insulin pricing next month, Chairman Bernie Sanders (I-Vt.) announced Friday. The CEOs from Eli Lilly and Company, Novo Nordisk and Sanofi will testify as Sanders uses his bully pulpit to continue pressuring the companies about the high cost of insulin, even though all three said they plan to lower the prices of older insulin products. ... + full article
Fox Business USA Business March 02, 2023
Arkansas Attorney General Leslie Rutledge provides insight into the conditions at the southern border as Title 42 is set to end and suing major pharma companies over raising the price of insulin. Eli Lilly is capping out-of-pocket costs for its insulin at $35 for patients,... + más
Eli Lilly To Lower Insulin Prices And Introduce A $35 Out-Of-Pocket Monthly Cap For Commercially Insured And Uninsured Diabetics | Forbes
Drugmaker Eli Lilly caps the cost of insulin at $35 a month, bringing relief for millions | NBC News
Forbes USA Tech March 01, 2023
This photo shows a vial of Eli Lilly's Humalog insulin. Eli Lilly will cut prices for several of its ... [+] insulin products later this year and introduce a monthly cap of $35 in out-of-pocket costs for commercially insured and uninsured patients. The moves announced March... + más
Eli Lilly caps out-of-pocket costs for insulin effective immediately | Fox Business
Eli Lilly plans to slash some insulin prices, expand cost cap | Portland Press Herald
The New York Times USA Health January 18, 2023
Many Americans with diabetes still struggle to pay for their insulin, even though Medicare placed a cap on co-payments this month.With a population of 39 million, California has now become the largest state to sue the major companies on the insulin market, accusing them of... + más
California latest to sue drug companies over insulin prices | ABC7
More than 1 million Americans ration their insulin as the drug's cost skyrockets | CBS News
ABC7 USA Health January 13, 2023
People are losing their lives because they can't afford the drug, Bonta said.Daphne Dorsey, associate director for media relations for Eli Lilly, said the company is disappointed by the California Attorney General's false accusations. She said the average... + más
California Joins Other States in Suing Companies Over Insulin Prices | The New York Times
Forbes USA Business November 13, 2022
This two-part article was researched and written in partnership with , President of Rumbly Health. delved into what a PBM is, why they are under scrutiny, and their eroding position in the market. Amazon, already one of the most highly-valued companies in the world, has been... + más
How To Get Away With Corporate Murder: Unbundling And Disrupting Pharmacy Benefit Managers (Part 1) | Forbes
Louisiana set to expand medical marijuana business, allow for new pharmacies | The Advocate
ABC News USA Health October 19, 2022
Nearly 30% of Americans living with diabetes who are uninsured may ration their insulin to save money, according to a .Researchers at Harvard Medical School, the City University of New York's Hunter College and consumer advocacy organization Public Citizen determined the... + más
3 in 10 uninsured Americans with diabetes may ration insulin: Study | ABC7
1.3 million Americans with diabetes rationed insulin in the past year, study finds | CNN
CBS News USA Health October 18, 2022
About 1.3 million Americans rationed their prescribed doses of insulin last year to save money, a pattern one doctor said threatens the health — and even the lives — of people with diabetes. Many people are taking less than the recommended amount of insulin as the cost of... + más
3 in 10 uninsured Americans with diabetes may ration insulin: Study | ABC News
About iurex | Privacy Policy | Disclaimer |